DTEA Fundamental Analysis - DAVIDSTEA INC

Fundamental Rating

Taking everything into account, DTEA scores 2 out of 10 in our fundamental rating. DTEA was compared to 17 industry peers in the Specialty Retail industry. While DTEA seems to be doing ok healthwise, there are quite some concerns on its profitability. DTEA has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year DTEA has reported negative net income.

In the past year DTEA had a positive cash flow from operations.

DTEA had negative earnings in 4 of the past 5 years.

The reported operating cash flow has been mixed in the past 5 years: DTEA reported negative operating cash flow in multiple years.

1.2 Ratios

With a Return On Assets value of -1.72%, DTEA is not doing good in the industry: 70.59% of the companies in the same industry are doing better.

DTEA's Return On Equity of -4.00% is on the low side compared to the rest of the industry. DTEA is outperformed by 70.59% of its industry peers.

		Industry Rank	Sector Rank
ROA	-1.72%
ROE	-4%
ROIC	N/A

ROA(3y)-20.71%

ROA(5y)-6.31%

ROE(3y)-41.53%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

DTEA's Gross Margin of 49.48% is fine compared to the rest of the industry. DTEA outperforms 70.59% of its industry peers.

In the last couple of years the Gross Margin of DTEA has declined.

DTEA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	49.48%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y5.52%

GM growth 5Y-2.86%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

DTEA does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, DTEA has more shares outstanding

Compared to 5 years ago, DTEA has more shares outstanding

DTEA has a worse debt/assets ratio than last year.

2.2 Solvency

DTEA has an Altman-Z score of -0.99. This is a bad value and indicates that DTEA is not financially healthy and even has some risk of bankruptcy.

DTEA's Altman-Z score of -0.99 is on the low side compared to the rest of the industry. DTEA is outperformed by 82.35% of its industry peers.

DTEA has a debt to FCF ratio of 2.30. This is a good value and a sign of high solvency as DTEA would need 2.30 years to pay back of all of its debts.

Looking at the Debt to FCF ratio, with a value of 2.30, DTEA is in the better half of the industry, outperforming 76.47% of the companies in the same industry.

A Debt/Equity ratio of 0.50 indicates that DTEA is somewhat dependend on debt financing.

The Debt to Equity ratio of DTEA (0.50) is comparable to the rest of the industry.

Although DTEA does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.

		Industry Rank	Sector Rank
Debt/Equity	0.5
Debt/FCF	2.3
Altman-Z	-0.99

ROIC/WACCN/A

WACC8.44%

2.3 Liquidity

DTEA has a Current Ratio of 1.85. This is a normal value and indicates that DTEA is financially healthy and should not expect problems in meeting its short term obligations.

DTEA has a better Current ratio (1.85) than 82.35% of its industry peers.

A Quick Ratio of 0.98 indicates that DTEA may have some problems paying its short term obligations.

Looking at the Quick ratio, with a value of 0.98, DTEA belongs to the top of the industry, outperforming 82.35% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.85
Quick Ratio	0.98

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 94.96% over the past year.

The Revenue has been growing slightly by 3.55% in the past year.

DTEA shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -20.65% yearly.

EPS 1Y (TTM)94.96%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%93.72%

Revenue 1Y (TTM)3.55%

Revenue growth 3Y-15.95%

Revenue growth 5Y-20.65%

Sales Q2Q%4.79%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DTEA. In the last year negative earnings were reported.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DTEA is on the same level as its industry peers.

82.35% of the companies in the same industry are more expensive than DTEA, based on the Price/Free Cash Flow ratio.

		Industry Rank	Sector Rank
P/FCF	4.81
EV/EBITDA	14.31

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for DTEA!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

DAVIDSTEA INC

TSX-V:DTEA (8/29/2025, 7:00:00 PM)

1.02

+0.01 (+0.99%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupConsumer Discretionary Distribution & Retail

GICS IndustrySpecialty Retail

Earnings (Last)06-17 2025-06-17/bmo

Earnings (Next)09-16 2025-09-16

Inst Owners11.22%

Inst Owner ChangeN/A

Ins Owners3.28%

Ins Owner ChangeN/A

Market Cap27.49M

Analysts45.71

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.44
P/FCF	4.81
P/OCF	4.01
P/B	1.51
P/tB	1.51
EV/EBITDA	14.31

EPS(TTM)-0.03

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)0.21

FCFY20.8%

OCF(TTM)0.25

OCFY24.95%

SpS2.3

BVpS0.68

TBVpS0.68

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-1.72%
ROE	-4%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	49.48%
FCFM	9.24%

ROA(3y)-20.71%

ROA(5y)-6.31%

ROE(3y)-41.53%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y5.52%

GM growth 5Y-2.86%

F-Score4

Asset Turnover1.46

Health

		Industry Rank	Sector Rank
Debt/Equity	0.5
Debt/FCF	2.3
Debt/EBITDA	4.34
Cap/Depr	29.41%
Cap/Sales	1.85%
Interest Coverage	N/A
Cash Conversion	324.46%
Profit Quality	N/A
Current Ratio	1.85
Quick Ratio	0.98
Altman-Z	-0.99

F-Score4

WACC8.44%

ROIC/WACCN/A

Cap/Depr(3y)36.98%

Cap/Depr(5y)24.87%

Cap/Sales(3y)2.08%

Cap/Sales(5y)1.41%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)94.96%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%93.72%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)3.55%

Revenue growth 3Y-15.95%

Revenue growth 5Y-20.65%

Sales Q2Q%4.79%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y83.4%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y207.55%

FCF growth 3YN/A

FCF growth 5Y-24.41%

OCF growth 1Y291.78%

OCF growth 3YN/A

OCF growth 5Y-23.2%

DAVIDSTEA INC (DTEA.CA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens